☰

Yu-Cheng Tseng, Ph.D. - Publications

Affiliations: 
2013 Pharmaceutical Sciences University of North Carolina, Chapel Hill, Chapel Hill, NC 
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Chen WH, Lecaros RL, Tseng YC, Huang L, Hsu YC. Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer. Cancer Letters. 359: 65-74. PMID 25596376 DOI: 10.1016/j.canlet.2014.12.052  0.451
2014 Tseng YC, Kan LP, Huang LY, Yin T, Yang YS, Lin JC, Siu LK. Successful treatment of a patient with ventriculoperitoneal shunt-associated meningitis caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. The Tohoku Journal of Experimental Medicine. 233: 301-5. PMID 25142281 DOI: DN/JST.JSTAGE/tjem/233.301  0.314
2014 Tseng YC, Xu Z, Guley K, Yuan H, Huang L. Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases. Biomaterials. 35: 4688-98. PMID 24613050 DOI: 10.1016/j.biomaterials.2014.02.030  0.416
2013 Tseng YC, Yang A, Huang L. How does the cell overcome LCP nanoparticle-induced calcium toxicity? Molecular Pharmaceutics. 10: 4391-5. PMID 24032396 DOI: 10.1021/mp400028m  0.355
2013 Xu Z, Ramishetti S, Tseng YC, Guo S, Wang Y, Huang L. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 172: 259-65. PMID 24004885 DOI: 10.1016/J.Jconrel.2013.08.021  0.543
2012 Liu Y, Tseng YC, Huang L. Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method? Pharmaceutical Research. 29: 3273-7. PMID 22806405 DOI: 10.1007/s11095-012-0818-1  0.39
2012 Chung C, Wang Y, Sheng W, Tseng Y, Dick T, Huang L, Robertson G. Abstract B10: Overcoming resistance to B-Raf targeting agents using LPD nanotechnology Clinical Cancer Research. 18: B10-B10. DOI: 10.1158/1078-0432.Mechres-B10  0.429
2010 Li J, Chen YC, Tseng YC, Mozumdar S, Huang L. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 416-21. PMID 19919845 DOI: 10.1016/j.jconrel.2009.11.008  0.542
2009 Tseng YC, Huang L. Self-assembled lipid nanomedicines for siRNA tumor targeting. Journal of Biomedical Nanotechnology. 5: 351-63. PMID 20055081  0.446
2009 Tseng YC, Mozumdar S, Huang L. Lipid-based systemic delivery of siRNA. Advanced Drug Delivery Reviews. 61: 721-31. PMID 19328215 DOI: 10.1016/J.Addr.2009.03.003  0.394
Show low-probability matches.